Shugui Yin

Title: Innovations by Inventor Shugui Yin

Introduction

Shugui Yin is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical preparation, particularly in the development of naltrexone implants. With a total of 2 patents to his name, his work showcases innovative approaches to drug delivery systems.

Latest Patents

One of Shugui Yin's latest patents is the "Preparation method of naltrexone implants." This invention involves a detailed process that includes dissolving naltrexone and polylactic acid in an organic solvent to create naltrexone microspheres, which are then dried. The microspheres are placed in a heated tableting mold to form naltrexone implant tablets. The process continues with the creation of a coating solution from polylactic acid, which is used to coat the implant tablets, ensuring a stable release of the drug.

Another significant patent is the "Implant coating and drying device." This device includes a chip sorter, a slide maker, a coating pool, a tablet pipe, a tablet conveying device, and a drying device. The design of the coating pool is a circular arc, which enhances the efficiency of the coating process. This invention addresses issues found in prior art, such as the adhesion of implant tablets and damage to the coating, making it suitable for mass production.

Career Highlights

Shugui Yin is associated with Shenzhen Sciencare Medical Industries Co. Ltd., where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in medical technology, particularly in the area of implantable drug delivery systems.

Collaborations

Shugui Yin has collaborated with notable colleagues, including Shiqiang Wang and Shaowei Jia. Their combined efforts have furthered research and development in the field of medical devices.

Conclusion

Shugui Yin's innovative contributions to pharmaceutical preparation and implant technology highlight his role as a leading inventor in the industry. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patient care and treatment outcomes.